Pregabalin Trial for the Treatment of Alcohol Use Disorder
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
In a 10-week randomized double-blind placebo-controlled outpatient pilot trial the efficacy
of pregabalin in the treatment of alcohol dependence will be studied in 50 treatment-seeking
outpatients. Participants will report drinking a minimum of 5 standard drinks for men or 4
standard drinks for women at least 4 days per week over the past 28 days.